Sylvia E. Escher, Falko Partosch, Sebastian Konzok, Paul Jennings, Mirjam Luijten, Anne Kienhuis, Victoria de Leeuw, Rosmarie Reuss, Katrina‐Magdalena Lindemann & Susanne Hougaard Bennekou. (2022) Development of a Roadmap for Action on New Approach Methodologies in Risk Assessment. EFSA Supporting Publications 19:6.
Crossref
Markus Fridén. 2022. Drug Delivery to the Brain. Drug Delivery to the Brain
437
458
.
Liang Han. (2021) Modulation of the Blood–Brain Barrier for Drug Delivery to Brain. Pharmaceutics 13:12, pages 2024.
Crossref
Liadys Mora Lagares, Nikola Minovski, Ana Yisel Caballero Alfonso, Emilio Benfenati, Sara Wellens, Maxime Culot, Fabien Gosselet & Marjana Novič. (2020) Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies. International Journal of Molecular Sciences 21:11, pages 4058.
Crossref
Anurag T. K. Baidya, Kalyan Ghosh, Sk. Abdul Amin, Nilanjan Adhikari, Jayabalan Nirmal, Tarun Jha & Shovanlal Gayen. (2020)
In silico
modelling, identification of crucial molecular fingerprints, and prediction of new possible substrates of human organic cationic transporters 1 and 2
. New Journal of Chemistry 44:10, pages 4129-4143.
Crossref
Santiago Vilar, Eduardo Sobarzo-Sánchez & Eugenio Uriarte. (2019) In Silico Prediction of P-glycoprotein Binding: Insights from Molecular Docking Studies. Current Medicinal Chemistry 26:10, pages 1746-1760.
Crossref
Yuichi Uwai. (2018) Enantioselective Drug Recognition by Drug Transporters. Molecules 23:12, pages 3062.
Crossref
Sean Ekins. (2016) The Next Era: Deep Learning in Pharmaceutical Research. Pharmaceutical Research 33:11, pages 2594-2603.
Crossref
Renata Silva, Vânia Vilas-Boas, Helena Carmo, Ricardo Jorge Dinis-Oliveira, Félix Carvalho, Maria de Lourdes Bastos & Fernando Remião. (2015) Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy. Pharmacology & Therapeutics 149, pages 1-123.
Crossref
Syed Subhani, Archana Jayaraman & Kaiser Jamil. (2015) Homology modelling and molecular docking of MDR1 with chemotherapeutic agents in non-small cell lung cancer. Biomedicine & Pharmacotherapy 71, pages 37-45.
Crossref
Hongming Chen, Susanne Winiwarter & Ola Engkvist. 2015. Blood-Brain Barrier in Drug Discovery. Blood-Brain Barrier in Drug Discovery
167
187
.
Kunal Roy, Supratik Kar & Rudra Narayan Das. 2015. Understanding the Basics of QSAR for Applications in Pharmaceutical Sciences and Risk Assessment. Understanding the Basics of QSAR for Applications in Pharmaceutical Sciences and Risk Assessment
455
462
.
Dan Li, Lei Chen, Youyong Li, Sheng Tian, Huiyong Sun & Tingjun Hou. (2014)
ADMET Evaluation in Drug Discovery. 13. Development of
in Silico
Prediction Models for P-Glycoprotein Substrates
. Molecular Pharmaceutics 11:3, pages 716-726.
Crossref
Monika I. Szabon-Watola, Sarah V. Ulatowski, Kathleen M. George, Christina D. Hayes, Scott A. Steiger & Nicholas R. Natale. (2014) Fluorescent probes of the isoxazole–dihydropyridine scaffold: MDR-1 binding and homology model. Bioorganic & Medicinal Chemistry Letters 24:1, pages 117-121.
Crossref
Markus Fridén. 2014. Drug Delivery to the Brain. Drug Delivery to the Brain
317
338
.
Serena Marchetti, Dick Pluim, Monique van Eijndhoven, Olaf van Tellingen, Roberto Mazzanti, Jos H. Beijnen & Jan H. M. Schellens. (2013) Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA. Investigational New Drugs 31:5, pages 1125-1135.
Crossref
Animikh Ray, Kishore Cholkar, Zhiying Wang & Ashim K. Mitra. 2013. Ocular Transporters and Receptors. Ocular Transporters and Receptors
85
114
.
Yurong Lai. 2013. Transporters in Drug Discovery and Development. Transporters in Drug Discovery and Development
675
718
.
S Ekins, J E Polli, P W Swaan & S H Wright. (2012) Computational Modeling to Accelerate the Identification of Substrates and Inhibitors for Transporters That Affect Drug Disposition. Clinical Pharmacology & Therapeutics 92:5, pages 661-665.
Crossref
Michaela Meyer, Sebastian Schneckener, Bernd Ludewig, Lars Kuepfer & Joerg Lippert. (2012) Using Expression Data for Quantification of Active Processes in Physiologically Based Pharmacokinetic Modeling. Drug Metabolism and Disposition 40:5, pages 892-901.
Crossref
Julio C. Davila & Jose E. Manautou. (2012) Drug Transporters. Current Protocols in Toxicology 52:1.
Crossref
Sean Ekins, Lei Diao & James E. Polli. (2012) A Substrate Pharmacophore for the Human Organic Cation/Carnitine Transporter Identifies Compounds Associated with Rhabdomyolysis. Molecular Pharmaceutics 9:4, pages 905-913.
Crossref
Lei Chen, Youyong Li, Huidong Yu, Liling Zhang & Tingjun Hou. (2012) Computational models for predicting substrates or inhibitors of P-glycoprotein. Drug Discovery Today 17:7-8, pages 343-351.
Crossref
Kenneth Bachmann & Sean Ekins. 2012. Predictive Approaches in Drug Discovery and Development. Predictive Approaches in Drug Discovery and Development
307
329
.
Sandhya Kortagere, Markus Lill & John Kerrigan. 2012. Computational Toxicology. Computational Toxicology
21
48
.
Ahmet Sacan, Sean Ekins & Sandhya Kortagere. 2012. Bioinformatics and Drug Discovery. Bioinformatics and Drug Discovery
87
124
.
Alessandro Pedretti, Laura De Luca, Cristina Marconi, Luca Regazzoni, Giancarlo Aldini & Giulio Vistoli. (2011) Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping. Bioorganic & Medicinal Chemistry 19:15, pages 4544-4551.
Crossref
David Lagorce, Christelle Reynes, Anne‐Claude Camproux, Maria A. Miteva, Olivier Sperandio & Bruno O. Villoutreix. 2011. ADMET for Medicinal Chemists. ADMET for Medicinal Chemists
29
124
.
Jihyun Shim & Alexander D. MacKerell, Jr.. (2011) Computational ligand-based rational design: role of conformational sampling and force fields in model development. MedChemComm 2:5, pages 356.
Crossref
Thomas N. Thompson. 2011. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development
285
313
.
Xiaochun Li-Blatter & Anna Seelig. (2010) Exploring the P-Glycoprotein Binding Cavity with Polyoxyethylene Alkyl Ethers. Biophysical Journal 99:11, pages 3589-3598.
Crossref
Rishi R. Gupta, Eric M. Gifford, Ted Liston, Chris L. Waller, Moses Hohman, Barry A. Bunin & Sean Ekins. (2010) Using Open Source Computational Tools for Predicting Human Metabolic Stability and Additional Absorption, Distribution, Metabolism, Excretion, and Toxicity Properties. Drug Metabolism and Disposition 38:11, pages 2083-2090.
Crossref
Kathleen M. Giacomini, Shiew-Mei Huang, Donald J. Tweedie, Leslie Z. Benet, Kim L.R. Brouwer, Xiaoyan Chu, Amber Dahlin, Raymond Evers, Volker Fischer, Kathleen M. Hillgren, Keith A. Hoffmaster, Toshihisa Ishikawa, Dietrich Keppler, Richard B. Kim, Caroline A. Lee, Mikko Niemi, Joseph W. Polli, Yuicchi Sugiyama, Peter W. Swaan, Joseph A. Ware, Stephen H. Wright, Sook Wah Yee, Maciej J. Zamek-Gliszczynski & Lei Zhang. (2010) Membrane transporters in drug development. Nature Reviews Drug Discovery 9:3, pages 215-236.
Crossref
Heidrun Potschka. (2010) Targeting regulation of ABC efflux transporters in brain diseases: A novel therapeutic approach. Pharmacology & Therapeutics 125:1, pages 118-127.
Crossref
Heidrun Potschka. 2010. Drug Delivery. Drug Delivery
411
431
.
Praveen M. Bahadduri, James E. Polli, Peter W. Swaan & Sean Ekins. 2010. Membrane Transporters in Drug Discovery and Development. Membrane Transporters in Drug Discovery and Development
65
103
.
K. Sandy Pang, Raimund M. Peter & A. David Rodrigues. 2010. Enzyme- and Transporter-Based Drug-Drug Interactions. Enzyme- and Transporter-Based Drug-Drug Interactions
701
722
.
Sean Ekins. 2009. Transporters as Drug Carriers. Transporters as Drug Carriers
215
227
.
Meryem KöseAnke C Schiedel. (2009) Nucleoside/nucleobase transporters: drug targets of the future?. Future Medicinal Chemistry 1:2, pages 303-326.
Crossref
Alessandro Pedretti, Laura De Luca, Cristina Marconi, Gianpaolo Negrisoli, Giancarlo Aldini & Giulio Vistoli. (2008) Modeling of the Intestinal Peptide Transporter hPepT1 and Analysis of Its Transport Capacities by Docking and Pharmacophore Mapping. ChemMedChem 3:12, pages 1913-1921.
Crossref
Agnès Poirier, Thierry Lavé, Renée Portmann, Marie-Elise Brun, Frank Senner, Manfred Kansy, Hans-Peter Grimm & Christoph Funk. (2008) Design, Data Analysis, and Simulation of in Vitro Drug Transport Kinetic Experiments Using a Mechanistic in Vitro Model. Drug Metabolism and Disposition 36:12, pages 2434-2444.
Crossref
Anna Seelig. 2008. Drug Bioavailability. Drug Bioavailability
497
519
.
Pascale Anderle & Carsten U. Nielsen. 2008. Drug Bioavailability. Drug Bioavailability
221
276
.